Cover Image

The Neuroprotective Effect of Atorvastatin on Apoptosis of Hippocampus Following Transient Global Ischemia/ Reperfusion

Masoumeh Faghani, Farhang Ejlali, Zahra Nadia Sharifi, Hassan Molladoost, Shabnam Movassaghi
Background: Hippocampus CA1 cells are highly sensitive to ischemia. Because of anti-oxida­tive property, atorvastatin by eliminating free radicals and other constituent due to cell lesions prevents damages or death of intact cells. The aim of this study is to determine neuroprotective effect of atorvastatin on apoptosis of hippocampus CA1 cells in male rats. Material and Meth­ods: In an experimental study 24 male rats –Wistar adult race- were divided into four groups: Ischemic, vehicle, treatment and control. In order to make an ischemic- reperfusion model, common carotid artery was clamped bilaterally for 20 minutes. In treatment group, the first dose of Atorvastatin (10mg/kg) was injected six hours after ischemic- reperfusion and 24, 48 and 72 later intraperitoneally. Four days after ischemic- reperfusion tissue section were obtained and stained using Nissl method. Then intact healthy pyramidal CA1 hippocampus cells were counted. TUKEY and One Way ANOVA were used for analyzing the obtained results. Results: No significant difference was found in numbers of healthy intake pyramidal and apoptotic cells of CA1 hippocampus region between treatment group (10mg/kg Atorvastatin) and controls, whereas a significant reduction of these cells was observed in ischemia and vehicle groups in comparison to controls (P<0.05). Conclusion: Using 10mg/kg atorvastatin following cerebral ischemia- reperfusion has a protective effect on pyramidal cells of CA1 region in hippocampus in male rats leading to reduction of degeneration and apoptosis.[GMJ.2016;5(2):82-89]
Atorvastatin; Hippocampus; Ischemia

Bokura H, Robinson RG. Long term cognitive impairment associated with caudate stroke. Stroke 1997; 28:970-975.

Braduik B, Sonesson B, Holtas S. Spatial impairment hallowing right hemisphere transient ischemic attackts in patients without carotid artery stenosis. Acta Neural Scand 1989; 80: 411-8.

Godefroy O, Rousseaux M, Pruro JP, Cabara M, Leys D. Neuropsychological changes related to unilateral lenticostriate infarcts. J Neurol Neurosurg Psychiatry 1994; 57(4):480-5

Petito CK, Feldmann E, Pulsinelli WA, Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 1987; 37: 1281-6.

Kesner RP, Adelstein T, Crutcher K. Equivalent spatial location memory deficits in rats with medial septum or hippocampal formation lesions and patients with dementia of the Alzheimer’s type. Brain Cogn 1989;9(2):289-300.

Alipanahzade H, Soleimani M, SoleimaniAsl S, Mehdizadeh M, Katebi M. Effect of transforming growth factor alpha of dentytejyrus neurons and pyramidal cells of CA1 subfiled of hippocampus following ischemia- reperfusion in Rats.J Gorgan Uni Med Sci 2012, 14(3): 26-32.

Deckert J, Jorgensen MB. Evidence for pre- and postsynaptic localization of adenosine A1 receptors in the CA1 region of rat hippocampus: a quantitative autoradiographic study. Brain Res 1988; 446(1): 161-4.

Zhang J, Piantadosi CA. Prolonged production of hydroxyl radical in rat hippocampus after brain ischemia-reperfusion is decreased by 21-aminosteroids. Neurosci Lett. 1994; 177(1-2):127-30.

Simonová Z, Sterbová K, Brozek G, Komárek V, Syková E. Postnatal hypobaric hypoxiain rats impairs water maze learning and morphology of neurones and macroglia in cortex and hippocampus. Behav Brain Res 2003; 141: 195-205.

Zini I, Tomasi A, Grimaldi R, Vannini V, Agnati LF. Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis. Neurosci Lett.1992; 138(2): 279-82.

Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982;11:491-8.

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-7.

Graaf MR. The risk of cancer in users of statins. J Clin Oncol. 2004; 22(12): 2388-94

Zacco A, Togo J, Spence K, Ellis A, Lloyd D, Furlong S, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J. Neurosci 2003; 23:11104-11.

Tanaka N, Katayama Y, Katsumata T, Otori T, Nishiyama Y. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats. Brain Res 2007; 1169: 125-32

Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 1998; 95: 8880–5.

Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 2005; 19(1): 117-25.

Kawai H, Deguchi SH, Deguchi K, Yamashita T, Ohta Y, Omote Y, et al. Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat. Brain Research 2011; 1382: 308-14.

Laufs U, Gertz K, Huang P, Nickenig G, Bohm M, Dirnagl U, et al. Atorvastatin upregulates type iii nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 2000; 31: 2442–9.

Clarke RM, Lyons A, O'Connell F, Deighan BF, Barry CE, Anyakoha NG, et al. A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain. J Biol Chem 2008; 283: 1808-17.

Céspedes-Rubio A, Jurado FW, Cardona-Gómez GP. p120 catenin/αN- catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia. J Neurosci Res. 2010; 88(16):3621-34

Zamani M, Rasooli H, Mehdizadeh M, Nobakht M, Zamani F, Soleimani M. Protective effect of Adenosine A1 receptor and ascorbic acid on hippocampal neuronal density and memory disorder in ischemia reperfusion induced Rats. J Gorgan Uni Med Sci. 2013; 14(4):52-9.

Kiernan JA. Histological, histochemical methods. 3rd Edition. Oxford: Butterworth Heinemann; 1999.

Waters DD. Safety of high-dose atorvastatin therapy. Am J Cardiol 2005; 96 (5A): 69F-75F.

Lu D, Goussev A, Chen J, Pannu P, Li Y, Mahmood A, Chopp M. Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J Neurotrauma 2004; 21(1): 21-32.

Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996; 27: 1124–1129.

Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. J Neurotrauma 2000 17: 871– 90.

Wityk RJ, Goldsborough MA, Hillis A, Beauchamp N, Barker PB, Borowicz LM Jr, et al. Diffusion and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery. Arch Neurol 2001; 58: 571–6.

Ruiz V. Statins upregulate CD 36 expressin in human monocytes an affect strengthened when combined with PPAR-gamma ligand putative contribution of Rho GTPase in statin-induced CD36 expression. Biochem Pharmacol. 2004; 67(2): 303-13.

Gertz K, Laufs U, Lindauer U, Nickenig G, Böhm M, Dirnagl U, et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 2003; 34: 551–7.

Elewa HF, Kozak A, El-Remessy AB, Frye RF, Johnson MH, Ergul A, et al. Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats. J Pharmacol Exp Ther 2009; 330(2): 532-540.

Weaver CE Jr, Park-Chung M, Gibbs TT, Farb DH. 17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 1997 Jul 4;761(2):338-41.

Cheng G, Wei L, Zhi-Dan S, Shi-Guang Z, Xiang-Zhen L. Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway. BMC Neurosci. 2009;10:7.

DoustarY, Mohajeri D. The anti-apoptotic effects of atorvastatin in isoproterenol induced experimental heart failure. ZJRMS 2011, 13(2): 13-9.

Laxman D, Zeng H. Atorvastatin inhibits Fas expression in ischemia-reperfusion induced myocardial cell injury. JRMS 2006; 11(3): 137-45.

Kawai H1, Deguchi S, Deguchi K, Yamashita T, Ohta Y, Omote Y, et al. Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat. Brain Res. 2011; 1382:308-14.

Céspedes-Rubio A1, Jurado FW, Cardona-Gómez GP. p120 catenin/αN-catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia. J Neurosci Res. 2010; 88(16):3621-34.

Refbacks

  • There are currently no refbacks.